You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, T-Cell

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Squamous Cell Carcinoma Trial (Paclitaxel, Irinotecan, Pembrolizumab)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Chuo-ku, Tokyo, Japan
    National Cancer Center Hospital ( Site 3700)
Jan 31, 2023

DLBCL Trial in Worldwide (Polatuzumab Vedotin, Rituximab, Gemcitabine)

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Polatuzumab Vedotin
  • +3 more
  • Hollywood, Florida
  • +89 more
Jan 31, 2023

NSCLC Trial in China (Pembrolizumab, Lenvatinib, Placebo for lenvatinib)

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer
  • Pembrolizumab
  • +2 more
  • Hefei, Anhui, China
  • +16 more
Oct 14, 2022

Gastric Cancer Trial in Copenhagen (Indocyanine green)

Recruiting
  • Gastric Cancer
  • Indocyanine green
  • Copenhagen, Kbh Ø, Denmark
    Rigshospitalet
Aug 30, 2022

Esophageal Squamous Cell Carcinoma (ESCC) Trial in Taiwan (BI-754091 plus afatinib)

Enrolling by invitation
  • Esophageal Squamous Cell Carcinoma (ESCC)
  • BI-754091 plus afatinib
  • Kaohsiung, Taiwan
  • +4 more
Aug 30, 2021

DNA Methylation Dynamics Underlying Arterial Remodeling in PAH

Completed
  • Pulmonary Arterial Hypertension
  • Pulmonary Arterial Remodeling
    • Naples, Italy
      Monaldi Hospital
    Jul 13, 2021

    Advanced Solid Tumors, Metastatic Solid Tumors Trial in Duarte, Cheongju-si (GDC-1971, Atezolizumab, Omeprazole)

    Recruiting
    • Advanced Solid Tumors
    • Metastatic Solid Tumors
    • Duarte, California
    • +1 more
    Aug 10, 2022

    Healthy Trial in Antwerpen (BI 1595043)

    Completed
    • Healthy
    • BI 1595043
    • Antwerpen, Belgium
      SGS Life Science Services - Clinical Research
    Aug 10, 2021

    naïve Age-related Macular Degeneration of Neovascular Type and

    Completed
    • Age-related Macular Degeneration
    • Data extraction from medical files
    • Brussels, Belgium
      CHU Brugmann
    Mar 7, 2022

    NSCLC Trial in Worldwide (DS-1062a)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • Phoenix, Arizona
    • +82 more
    Jul 27, 2022

    Heel Fat Pad Atrophy Trial in Pittsburgh (Heel Fat Grafting)

    Completed
    • Heel Fat Pad Atrophy
    • Heel Fat Grafting
    • Pittsburgh, Pennsylvania
      UPMC Department of Plastic Surgery
    May 17, 2022

    Gingival Recession Trial in Konya (COMPARISON OF PLATELET-RICH FIBRIN PREPARED WITH TITANIUM AND SUBEPITHELIAL CONNECTIVE TISSUE

    Completed
    • Gingival Recession
    • COMPARISON OF PLATELET-RICH FIBRIN PREPARED WITH TITANIUM AND SUBEPITHELIAL CONNECTIVE TISSUE GRAFT
    • Konya, Meram, Turkey
    • +1 more
    Feb 26, 2022

    Triple Negative Breast Cancer, PD-L1 Positive Trial in Puerto Rico, United States (Sacituzumab Govitecan-hziy, Pembrolizumab,

    Recruiting
    • Triple Negative Breast Cancer
    • PD-L1 Positive
    • Sacituzumab Govitecan-hziy
    • +5 more
    • Anchorage, Alaska
    • +245 more
    Jan 12, 2023

    Electromagnetic Radiation (5GFR2) Trial (5GFR2 non ionizing EMW exposure)

    Not yet recruiting
    • Electromagnetic Radiation (5GFR2)
    • 5GFR2 non ionizing EMW exposure
    • (no location specified)
    Jun 28, 2023

    Lung Cancer Trial in Manchester (Once daily radiotherapy, Twice daily radiotherapy)

    Completed
    • Lung Cancer
    • Once daily radiotherapy
    • Twice daily radiotherapy
    • Manchester, United Kingdom
      The Christie NHS Foundation Trust
    Sep 5, 2022

    ARDS, Acute Respiratory Distress Syndrome, Covid19 Trial in Amsterdam (Imatinib Mesylate intravenous solution, Placebo)

    Recruiting
    • ARDS
    • +4 more
    • Imatinib Mesylate intravenous solution
    • Placebo
    • Amsterdam, Noord-Holland, Netherlands
    • +1 more
    Mar 23, 2021

    HER2-positive Breast Cancer Trial in Tampa (biological, drug, procedure)

    Recruiting
    • HER2-positive Breast Cancer
    • HER-2 pulsed DC1
    • +4 more
    • Tampa, Florida
      Moffitt Cancer Center
    Oct 6, 2022

    Urothelial Carcinoma Bladder, Androgen Receptor Positive Trial in Providence (Degarelix, Gemcitabine/Cisplatin)

    Not yet recruiting
    • Urothelial Carcinoma Bladder
    • Androgen Receptor Positive
    • Providence, Rhode Island
      Lifespan Cancer Institute
    May 1, 2023

    COVID-19 Vaccine in Autoimmune and Inflammatory Diseases Treated

    Terminated
    • Autoimmune Diseases
    • Inflammatory Disorder
    • Blood sample
    • Paris, France
      Internal medicine Service - Cochin Hospital
    Dec 7, 2022

    Acute Myeloid Leukemia Trial in Heidelberg (Gemtuzumab Ozogamicin 147, Gemtuzumab Ozogamicin 1, Glasdegib)

    Terminated
    • Acute Myeloid Leukemia
    • Gemtuzumab Ozogamicin 147
    • +3 more
    • Heidelberg, Baden-Württemberg, Germany
      University Hospital Heidelberg, Internal Medicine V
    Jun 27, 2022

    Localized Lung Carcinoma, Locally Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Carcinoma Trial in United States

    Suspended
    • Localized Lung Carcinoma
    • +10 more
    • Accelerated Hypofractionated Radiation Therapy
    • +2 more
    • Atlanta, Georgia
    • +55 more
    Jan 10, 2023

    Local Advanced Esophageal Carcinoma

    Recruiting
    • Esophageal Squamous Cell Carcinoma
      • Shanghai, Shanghai, China
        Fudan University Shanghai cancer center
      Jun 16, 2022

      Relapsed or Refractory B-cell Hematologic Malignancies Trial in Beijing, Nanjing (HEC89736)

      Active, not recruiting
      • Relapsed or Refractory B-cell Hematologic Malignancies
      • Beijing, Beijing, China
      • +1 more
      May 5, 2022

      Locally Advanced Basal Cell Carcinoma Trial in Philadelphia (biological, procedure, other)

      Not yet recruiting
      • Locally Advanced Basal Cell Carcinoma
      • Cemiplimab
      • +3 more
      • Philadelphia, Pennsylvania
        Thomas Jefferson University Hospital
      Jun 28, 2023

      Squamous Cell Cancers of the Head and Neck Trial in New Haven (cetuximab, afatinib)

      Recruiting
      • Squamous Cell Cancers of the Head and Neck
      • New Haven, Connecticut
        Yale Cancer Center
      Jan 10, 2023